Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Appointed director
CC transcript
Quarterly results
PURE BIOSCIENCE, INC. (PURE) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/10/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "CONVERTIBLE PROMISSORY NOTE",
"NOTE PURCHASE AGREEMENT THIS NOTE PURCHASE AGREEMENT is made as of June 30, 2023, by and among Pure Bioscience, Inc., a Delaware corporation , and the lenders named on Schedule 1 attached hereto . Capitalized terms not otherwise defined in this Agreement shall have the meanings ascribed to them in Section 1 below. 1. Definitions . “ Action ” shall have the meaning ascribed to such term in Section 4.9 . “ Affiliate ” shall mean any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person as such terms are used in and construed under Rule 144 under the Securities Act. With respect to a Lender, any investment fund or managed account that is managed on a discretionary basis by the same investment manager as su..."
03/21/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/17/2023 10-Q Quarterly Report for the period ended January 31, 2023
03/17/2023 8-K Quarterly results
Docs: "PURE Bioscience Reports Fiscal 2023 Second Quarter And Six-Month Financial Results"
02/10/2023 8-K Quarterly results
12/23/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
12/14/2022 10-Q Quarterly Report for the period ended October 31, 2022
12/14/2022 8-K Quarterly results
10/28/2022 10-K Annual Report for the period ended July 31, 2022
10/28/2022 8-K Quarterly results
07/19/2022 8-K Quarterly results
06/14/2022 10-Q Quarterly Report for the period ended April 30, 2022
06/14/2022 8-K Quarterly results
03/15/2022 10-Q Quarterly Report for the period ended January 31, 2022
03/15/2022 8-K Quarterly results
Docs: "PURE Bioscience Reports Fiscal 2022 Second Quarter And Six-Month Financial Results"
02/08/2022 8-K Quarterly results
01/26/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
12/20/2021 DEF 14A Form DEF 14A - Other definitive proxy statements:
12/15/2021 10-Q Quarterly Report for the period ended October 31, 2021
12/15/2021 8-K Quarterly results
10/28/2021 10-K Annual Report for the period ended July 31, 2021
10/28/2021 8-K Quarterly results
Docs: "PURE Bioscience Reports Fiscal 2021 Financial Results"
08/23/2021 8-K Other Events
06/15/2021 10-Q Quarterly Report for the period ended April 30, 2021
06/15/2021 8-K Quarterly results
05/19/2021 8-K Quarterly results
03/15/2021 10-Q Quarterly Report for the period ended January 31, 2021
03/15/2021 8-K Quarterly results
01/27/2021 8-K Submission of Matters to a Vote of Security Holders
12/15/2020 10-Q Quarterly Report for the period ended October 31, 2020
12/15/2020 8-K Quarterly results
Docs: "PURE Bioscience Reports Fiscal First Quarter 2021 Financial Results"
12/08/2020 DEF 14A Form DEF 14A - Other definitive proxy statements:
11/20/2020 PRE 14A Form PRE 14A - Other preliminary proxy statements:
10/26/2020 EFFECT Form EFFECT - Notice of Effectiveness:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy